AMAG Pharmaceuticals Inc $18.50

down -0.54


24/7/2014 04:00 PM  |  NASDAQ : AMAG  
Industries : Drugs / Diagnostic Substances
Get Trend Analysis Icon Get AMAG Trend Analysis - it has underperformed the S&P 500 by 37%

Partner Headlines

  1. AMAG Pharma Announces Publication of Data from Trial of MuGard in the Journal ...

    Benzinga
  2. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Lowest ...

    Benzinga
  3. Benzinga's Top #PreMarket Losers

    Benzinga
  4. US Stock Futures Down Ahead Of Earnings

    Benzinga
  5. UPDATE: AMAG Pharmaceuticals Receives CRL from FDA for Supplemental NDA ...

    Benzinga
  6. Earnings Scheduled For January 15, 2014

    Benzinga
  7. Market Wrap For December 31: Markets End The Year On A Positive Note

    Benzinga
  8. AMAG Pharmaceuticals Update Announces Preliminary 2012 Financial Results ...

    Benzinga
  9. AMAG Pharmaceuticals, Inc. (AMAG) EVP, COO Frank E Thomas sells 10,000 ...

    GuruFocus
  10. AMAG Pharma Submits Supplemental NDA for Feraheme

    Benzinga
  11. AMAG Pharma Reports New Data from Ferumoxytol Pivotal Phase III Broad Iron ...

    Benzinga
  12. AMAG Pharmaceuticals Inc. (AMAG) EVP, COO Frank E Thomas sells 5,000 Shares

    GuruFocus
  13. AMAG Pharmaceuticals Inc. (AMAG) EVP, COO Frank E Thomas sells 5,000 Shares

    GuruFocus
  14. AMAG Pharmaceuticals, Inc. (AMAG) EVP, COO Frank E Thomas sells 5,000 Shares

    GuruFocus
  15. Rienso Receives Swiss Marketing Authorization for the Treatment of Iron ...

    Benzinga
  16. AMAG Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  17. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ...

    Benzinga
  18. Financial Breakfast: Morning News Summary for July 18, 2012

    Benzinga
  19. AMAG Pharmaceuticals Announces Positive Preliminary Results from its Phase ...

    Benzinga
  20. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ...

    Benzinga
  21. AMAG Pharmaceuticals Realigns Operating Cost Structure; Expects to Reduce ...

    Benzinga
  22. UPDATE: Ladenburg Thalmann Upgrades AMAG Pharmaceuticals to Buy

    Benzinga
  23. Benzinga's Top Downgrades With Color for May 10, 2012

    Benzinga
  24. UPDATE: Ladenburg Thalmann Downgrades AMAG Pharmaceuticals; Removes PT

    Benzinga
  25. AMAG Pharmaceuticals Appoints William Heiden as President and Chief Executive ...

    Benzinga
  26. UPDATE: Ladenburg Thalmann Lowers AMAG Pharmaceuticals PT

    Benzinga
  27. AMAG Pharmaceuticals Reports Mixed Q4 Results

    Benzinga
  28. AMAG Pharmaceuticals Reports Mixed Q4 Results

    Benzinga
  29. UPDATE: JP Morgan Downgrades AMAG Pharmaceuticals to Underweight, Reduces ...

    Benzinga
  30. JP Morgan Downgrades AMAG Pharmaceuticals to Underweight

    Benzinga
  31. JP Morgan Downgrades AMAG Pharmaceuticals to Underweight

    Benzinga
  32. JP Morgan Downgrades AMAG Pharmaceuticals to Underweight

    Benzinga
  33. McNicoll Lewis Vlak Lowers PT on AMAG Pharmaceuticals to $21

    Benzinga
  34. AMAG Pharmaceuticals Sees Q4 Revenues of $14.3-15.0M vs $16.11M

    Benzinga
  35. Top 4 NASDAQ Stocks In Diagnostic Substances Industry With The Highest ...

    Benzinga
  36. McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23

    Benzinga
  37. Health Canada Approves Feraheme to Treat Iron Deficiency Anemia in Adults ...

    Benzinga
  38. AMAG Pharmaceuticals Announces Preliminary Data Regarding the Safety and ...

    Benzinga
Trading Center